Breakthrough cancer medicine and its impact on novel drug development in China:report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting

doi:10.5732/cjc.014.10246

	Breakthrough cancer medicine and its impact on novel drug development in China:report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting
	Luo Feng Roger 1; Ding Jian 2; Chen Helen X 1; Liu Hao 3; Fung Mancheong 4; Koehler Maria 5; Armand Jean Pierre 6; Jiang Lei 2; Xu Xiao 1; Zhang Ge 7
刊名	Chinese Journal of Cancer
	2014
卷号	33 期号:12 页码:620
关键词	CELL LUNG-CANCER GASTRIC-CANCER BREAST-CANCER INHIBITOR PCI-32765 IBRUTINIB Breakthrough clinical trial cancer medicine
ISSN号	1000-467X
DOI	10.5732/cjc.014.10246
英文摘要	The US Chinese Anti-Cancer Association (USCACA) teamed up with Chinese Society of Clinical Oncology (CSCO) to host a joint session at the 17th CSCO Annual Meeting on September 20th, 2014 in Xiamen, China. With a focus on breakthrough cancer medicines, the session featured innovative approaches to evaluate breakthrough agents and established a platform to interactively share successful experiences from case studies of 6 novel agents from both the United States and China. The goal of the session is to inspire scientific and practical considerations for clinical trial design and strategy to expedite cancer drug development in China. A panel discussion further provided in-depth advice on advancing both early and full development of novel cancer medicines in China.
语种	英语
内容类型	期刊论文
源URL	[http://119.78.100.183/handle/2S10ELR8/285505]
专题	中国科学院上海药物研究所
作者单位	1.The US Chinese Anti-Cancer Association 2.中国科学院上海药物研究所 3.Novartis Pharmaceuticals Oncology 4.Department of Oncology, Janssen Research & Development, LLC 5.Pfizer Oncology 6.Institut Gustave Roussy, Cancer Campus Grand Paris, 114 rue Edouard-Vaillant 7.Jiangsu Hengrui Medicine Co., Ltd.
推荐引用方式 GB/T 7714	Luo Feng Roger,Ding Jian,Chen Helen X,et al. Breakthrough cancer medicine and its impact on novel drug development in China:report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting[J]. Chinese Journal of Cancer,2014,33(12):620.
APA	Luo Feng Roger.,Ding Jian.,Chen Helen X.,Liu Hao.,Fung Mancheong.,...&Yan Li.(2014).Breakthrough cancer medicine and its impact on novel drug development in China:report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting.Chinese Journal of Cancer,33(12),620.
MLA	Luo Feng Roger,et al."Breakthrough cancer medicine and its impact on novel drug development in China:report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting".Chinese Journal of Cancer 33.12(2014):620.